Sermorelin
Sermorelin
Growth Hormone Axis
Sermorelin is indexed as peptide in the PeptideBase article library. It is referenced in “Peptide Therapy Explained: What Clinics Mean, What’s Evidence-Based, and What’s Marketing” and 2 other PeptideBase articles. This page groups the relevant coverage; evidence strength, safety, and clinical relevance depend on the specific claim and source.
Deep Dives on Sermorelin
Start here for the plain-English articles connected to this peptide.
What Is Tesamorelin? Visceral Fat Claims, Growth-Hormone Pathways, and Evidence
Evidence-aware explanation of tesamorelin, why it is searched around visceral fat and body composition, what the HIV-associated VAT evidence supports, how GH/IGF-1 pathway claims are often generalized, and where side-effect boundaries matter.
Read articleSermorelin vs Ipamorelin: What’s the Difference?
Sermorelin and ipamorelin are both discussed as growth-hormone-secretagogue-related peptides, but they differ by pathway, evidence base, and safety uncertainty.
Read articlePeptide Therapy Explained: What Clinics Mean, What’s Evidence-Based, and What’s Marketing
A cautious, evidence-aware guide to what peptide therapy means in clinics and marketing, how approved medicines differ from research compounds, and what questions to ask before trusting a claim.
Read articleQuick Facts
- Origin
- Named peptide referenced in PeptideBase coverage
- Category
- Growth Hormone Axis